Table 1.
Total | Adenocarcinoma | Neuroendocrine tumor | Clinically diagnosed malignancy | Pancreatitis | Others | |
Hypoenhancement | 66 | 57 | 1 | 2 | 6 | 0 |
Isoenhancement | 8 | 2 | 0 | 0 | 5 | 1 |
Hyperenhancement | 16 | 3 | 2 | 0 | 8 | 3 |
Total | 62 | 3 | 2 | 19 | 4 |
Total | Adenocarcinoma | Neuroendocrine tumor | Clinically diagnosed malignancy | Pancreatitis | Others | |
Hypoenhancement | 66 | 57 | 1 | 2 | 6 | 0 |
Isoenhancement | 8 | 2 | 0 | 0 | 5 | 1 |
Hyperenhancement | 16 | 3 | 2 | 0 | 8 | 3 |
Total | 62 | 3 | 2 | 19 | 4 |